CTRP3/AMPK pathway plays a key role in the anti-hypertrophic effects of cyanidin-3-O-glucoside by inhibiting the inflammatory response
Advances in Clinical and Experimental Medicine · 2023
DOI: 10.17219/acem/172546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Xueli Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Ganzhou People's Hospital, China. Hauptthemen laut MEDLINE: Anthocyanins, Cardiomegaly, Myocytes, Cardiac, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Ganzhou People's Hospital, China.
Zitieren
APA
Zhang, X., & Qin, X. (2023). CTRP3/AMPK pathway plays a key role in the anti-hypertrophic effects of cyanidin-3-O-glucoside by inhibiting the inflammatory response. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/172546
Vancouver
Zhang X, Qin X. CTRP3/AMPK pathway plays a key role in the anti-hypertrophic effects of cyanidin-3-O-glucoside by inhibiting the inflammatory response. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/172546
BibTeX
@article{Zhang2023,
author = {Zhang, Xueli and Qin, Xiaoyi},
title = {CTRP3/AMPK pathway plays a key role in the anti-hypertrophic effects of cyanidin-3-O-glucoside by inhibiting the inflammatory response},
journal = {Advances in Clinical and Experimental Medicine},
year = {2023},
doi = {10.17219/acem/172546}
}
EUVIMED